Delta Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-43
Closed -$5K 587
2020
Q3
$5K Hold
43
﹤0.01% 476
2020
Q2
$5K Hold
43
﹤0.01% 489
2020
Q1
$3K Hold
43
﹤0.01% 535
2019
Q4
$5K Hold
43
﹤0.01% 517
2019
Q3
$5K Hold
43
﹤0.01% 505
2019
Q2
$4K Hold
43
﹤0.01% 464
2019
Q1
$4K Hold
43
﹤0.01% 461
2018
Q4
$4K Hold
43
﹤0.01% 525
2018
Q3
$5K Hold
43
﹤0.01% 534
2018
Q2
$5K Hold
43
﹤0.01% 527
2018
Q1
$4K Hold
43
﹤0.01% 544
2017
Q4
$4K Hold
43
﹤0.01% 529
2017
Q3
$4K Hold
43
﹤0.01% 502
2017
Q2
$5K Hold
43
﹤0.01% 482
2017
Q1
$4K Buy
+43
New +$4.1K ﹤0.01% 523

Other funds holding DGX

Delta Asset Management's DGX Position: Q4 2020 in Review

Delta Asset Management sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 43 shares — an estimated $5K sold.

Delta Asset Management first reported a position in DGX in Q1 2017 and held it in 15 quarters. The position peaked at $5K in Q3 2020. 811 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

  • Delta Asset Management reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Delta Asset Management sold 43 Quest Diagnostics shares in Q4 2020, an estimated $5K.
  • Delta Asset Management first reported a position in Quest Diagnostics in Q1 2017 and held it in 15 quarters.
  • Delta Asset Management's Quest Diagnostics position peaked at $5K in Q3 2020.
  • 811 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on Delta Asset Management's 13F filing for Q4 2020, filed 2 Feb 2021.